Quantcast

Latest Sequenom Stories

2014-03-03 08:30:45

SAN DIEGO, March 3, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 26(th) Annual Roth Conference at the Ritz Carlton in Dana Point, CA on March 9-12, 2014. William Welch, President and Chief Operating Officer, and Carolyn D. Beaver, Vice President and Chief Accounting Officer, will present on Tuesday, March 11, beginning at...

2014-02-27 16:28:32

Record Quarterly and Annual Revenues; Annual Growth of 81% Over Prior Year SAN DIEGO, Feb. 27, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $45.1 million for the fourth quarter and $162.4 million for the full year of 2013. Net loss was $18.9 million, or $0.16 per share, for the fourth quarter and $107.4 million, or $0.93 per share, for the full year. Recent Key...

2014-02-14 08:26:21

DUBLIN, Feb. 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kkxpsb/molecular ) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics Markets" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The technologies that constitute molecular diagnostics - like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and...

2014-02-13 08:30:15

SAN DIEGO, Feb. 13, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the fourth quarter and full year of 2013 after closing of the NASDAQ Global Market on Thursday, February 27, 2014. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at...

2014-02-05 16:26:28

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/r5d88l/molecular) has announced the addition of the "Concise Analysis of International Molecular Diagnostics in Genetic Testing" [http://www.researchandmarkets.com/research/r5d88l/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics in genetic testing brings advanced analytical techniques to...

2014-02-03 20:22:36

DUBLIN, February 3, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6cwsz6/molecular) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/6cwsz6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with...

2014-01-16 20:22:14

Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or "wet" age-related macular degeneration (AMD) SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (NASDAQ:SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an...

2014-01-16 16:24:23

DUBLIN, January 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/322q6g/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/322q6g/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal...

2014-01-14 16:26:12

SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, entered into an agreement to offer access to its MaterniT21(TM) PLUS laboratory-developed test to Mayo Medical Laboratories. "We are delighted to expand our offerings to our national clients to offer the MaterniT21 PLUS test to physicians who have patients who...

2014-01-12 12:20:22

SAN DIEGO, Jan. 12, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company's 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) -- Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 -- Diagnostic services...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related